Tuesday, September 28, 2021
Tags Bharat Biotech

Tag: Bharat Biotech

Covaxin effective against delta plus variant of COVID-19: ICMR Study

Experts have speculated that the Delta Plus variant may be responsible for the third wave of COVID-19.

Bharat Biotech submits all documents to WHO for emergency use listing of Covaxin

EUL is necessary for vaccine companies to supply their vaccines for international procurement.

Bharat Biotech’s Covaxin likely to get WHO’s approval soon

WHO Chief Scientist Dr. Soumya Swaminathan said that the data of Covaxin trial "looks good".

Covaxin found to be 77.8% effective in the third phase trial

Covaxin has been found to be 65% effective against the delta variant of the COVID-19.

Bharat Biotech likely to have pre-submission meeting with WHO today for Covaxin

Covaxin has been found to be 77.8% effective in the third phase trial.

Bharat Biotech submits data for Phase III trial of Covaxin

Bharat Biotech had released interim data for Phase III trials in March.

Bharat Biotech and WHO pre-submission meeting scheduled on June 23rd

Bharat Biotech's COVID-19 vaccine 'Covaxin' may get approval from the WHO soon.

AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials from Tuesday

AIIMS Delhi will next conduct trials on 2-6 years age group children after this trial.

AIIMS Delhi starts screening children for Covaxin trials from today

AIIMS Delhi will study the effect of the vaccine on children and the body's immunity.

DCGI approves Covaxin clinical trials in children of age group 2 to 18 years

Bharat Biotech will now conduct trial of the vaccine in 525 healthy volunteers.

Most Read